Citation 84878

MORITA,H: ARISAKA,M: YOSHIDA,N: KOBAYASHI,JI:. (2000). CEPHALEZOMINES A-F, POTENT CYTOTOXIC ALKALOIDS FROM CEPHALOTAXUS HARRINGTONIA VAR. NANA.. 56(19)

Citation Details

Title	CEPHALEZOMINES A-F, POTENT CYTOTOXIC ALKALOIDS FROM CEPHALOTAXUS HARRINGTONIA VAR. NANA.
Authors	MORITA,H: ARISAKA,M: YOSHIDA,N: KOBAYASHI,JI:
Year	2000
Volume	56
Issue	19

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Cephalotaxus harringtonia (CEPHALOTAXACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CEPHALEZOMINE A	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE A	STRONG ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE A	STRONG ACTIVITY
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CEPHALEZOMINE B	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE B	STRONG ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE B	STRONG ACTIVITY
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CEPHALEZOMINE C	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE C	STRONG ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE C	STRONG ACTIVITY
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CEPHALEZOMINE D	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE D	WEAK ACTIVITY
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE D	STRONG ACTIVITY
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CEPHALEZOMINE E	None
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE E	STRONG ACTIVITY
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE E	STRONG ACTIVITY
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CEPHALEZOMINE F	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE F	STRONG ACTIVITY
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALEZOMINE F	STRONG ACTIVITY
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DRUPACINE	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DRUPACINE	STRONG ACTIVITY
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DRUPACINE	STRONG ACTIVITY
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CEPHALOTAXINONE,DEMETHYL:	None
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALOTAXINONE,DEMETHYL:	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALOTAXINONE,DEMETHYL:	STRONG ACTIVITY
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CEPHALOTAXINE	None
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALOTAXINE	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALOTAXINE	STRONG ACTIVITY
28	Not specified	ISOLATION AND IDENTIFICATION OF	CEPHALOTAXINE,11-HYDROXY:	None
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALOTAXINE,11-HYDROXY:	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEPHALOTAXINE,11-HYDROXY:	STRONG ACTIVITY
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HARRINGTONINE,ISO:SCHELHAMMERICINE B,EPI:	None
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCHELHAMMERICINE B,EPI:	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCHELHAMMERICINE B,EPI:	ACTIVE
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SCHELHAMMERICINE,3-EPI:	None
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCHELHAMMERICINE,3-EPI:	STRONG ACTIVITY
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCHELHAMMERICINE,3-EPI:	STRONG ACTIVITY
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HARRINGTONINE	None
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE	ACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE	STRONG ACTIVITY
40	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HARRINGTONINE,HOMO-DEOXY:	None
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE,HOMO-DEOXY:	STRONG ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE,HOMO-DEOXY:	STRONG ACTIVITY
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HARRINGTONINE,DEOXY:	None
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE,DEOXY:	STRONG ACTIVITY
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE,DEOXY:	STRONG ACTIVITY
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE,ISO:	STRONG ACTIVITY
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HARRINGTONINE,ISO:	STRONG ACTIVITY

Citation 84878

Citation Details

Summary

Organisms and Their Experiments (1)

Cephalotaxus harringtonia (CEPHALOTAXACEAE)

Show SPARQL Queries (1)

Query 1